Drug Law Center gives you the information you need to explore your legal options.
Smiling elderly woman
Justia Badge for Jonathan Rosenfeld
American Association for Justice Badge
Million Dollar Advocates Forum Badge
Super Lawyers Badge
BBB Badge
Avvo Raiting
Attorney & Publisher Jonathan Rosenfeld
Attorneys for Valsartan Users With Stomach, Colon & Liver Cancer

Valsartan is a popular medication prescribed by doctors to treat high blood pressure and heart failure. The patent on Valsartan has expired and is also known as Losartan, Irbesartan, Azilsartan, Olmesartan, Eprosartan, Candesartan and Telmisartan.

In July, 2018 Valsartan (and other similar angiotensin II receptor blocker medications) were ordered recalled from the market by the FDA when it was discovered that lots were contaminated with N-nitrosodimethylamine (NDMA) due to a defect with the manufacturing process. The concern about NDMA is that it is widely considered to be a carcinogen.

The attorneys at the Drug Law Center LLC are currently investigating cases where people have developed cancer after taking Valsartan (and similar medications) from 2015 through present.

If you or a family member took Valsartan and developed one of the below cancers or injuries, we are interested in speaking with you regarding your legal options and joining pending lawsuits.

The following cases are being reviewed:

  • Liver cancer
  • Colorectal cancer
  • Stomach cancer
  • Liver injury with hospitalization

Contact us today for a Free Valsartan lawsuit case review.

Published on:

Recall of Valsartran that can be contaminatedFDA Issues a Recall Warning over Concerns That Some Valsartan is Contaminated With Carcinogens

In July 2018, the FDA (Food and Drug Administration) began recalling drugs containing valsartan. The federal agency stated that the medication to treat heart failure and high blood pressure contained a toxic chemical. The chemical N-nitrosodimethylamine (NDMA) compound has known carcinogenic properties.

The attorneys are the Drug Law Center LLC are currently review Valsartan cancer lawsuits involving the following types of cancer / injury:

  • Liver cancer
  • Stomach cancer
  • Colon cancer
  • Liver damage with hospitalization

If you or a loved one took Valsartan from 2015 to present and developed one of the above complications, you may be entitled to file a lawsuit against the manufacturers or other entities to recover compensation. Begin the legal process and contact a Valsartan cancer attoreny today.

What is Valsartan?

Valsartan (Diovan) is a popular medication prescribed by doctors to treat congestive heart failure (CHF) and high blood pressure. The drug is classified as an ARB (angiotensin receptor blocker) that is used to extend life longevity after a patient suffers a heart attack. Doctors prescribed valsartan to patients who have previously suffered from heart failure because the medication is known to relax blood vessels and improve circulatory issues and blood flow. The medication helps to lower high blood pressure and can prevent kidney problems, heart issues and stroke.

The FDA approved valsartan for the use in numerous generic medications to treat left ventricular dysfunction, left ventricular failure, heart failure, and hypertension. The medication as prescribed in varying doses and is sometimes combined with hydrochlorothiazide (HCTZ) for the treatment of hypertension.

NDMA Linked to Valsartan

Recently, Chinese drug manufacturer Zhejiang Huahai Pharmaceutical issued a release stating that N-nitrosodimethylamine had been discovered in their generic valsartan products. The pharmaceutical company was supplying the impure medication containing NDMA to drug companies in the United States including Major Pharmaceuticals, Teva Pharmaceuticals Industries Ltd. and Solco Healthcare.

Once the contaminated products were acquired, these drug companies processed the medication and distributed tainted valsartan pills and tablets to the American pharmaceutical market. For years, these companies have made the drug available to consumers.

What is N-nitrosodimethylamine?

Information supplied by the International Agency for Research on Cancer (IARC) reveals that N-nitrosodimethylamine (NDMA):

  • Is a highly toxic organic chemical compound;
  • Is used in various products from liquid rocket fuel to softeners and lubricants;
  • Can be created through a chemical reaction during the manufacturing process;
  • Has been classified as a manufacturing byproduct created when making rubber tires, formulating pesticides and processing fish;
  • Has been detected in trace amounts in some foods that can be released through a chemical reaction while the food is being processed;
  • Can be created when salting, browning or grilling some meats.

Researchers have identified N-nitrosodimethylamine has been linked to cancer in animals that formed cancerous tumors in the respiratory tract, kidney and liver. NDMA is also associated with nasal cancer, lung cancer, kidney cancer, colorectal cancer, gastric cancer and liver cancer and might likely cause other cancerous conditions in all organs. Because of the animal testing results, scientists have label NDMA as a probable human carcinogen, making them highly dangerous to everyone.

A Voluntary Recall

On July 13, 2018, the FDA released a safety communication warning announcing that pharmaceutical medications containing contaminated valsartan would be voluntarily recall from the medical marketplace. The federal agency released a list of other medications containing unadulterated valsartan that were not being pulled from the pharmaceutical marketplace.

The products that were recall were processed and distributed by specific drug companies.

July 2018 Voluntarily Recall Valsartan Medication

DRUG COMPANY RECALLED MEDICINE:

  • Major Pharmaceuticals Valsartan – 80 mg and 160 mg tablets
  • Solco Healthcare LLC Valsartan – 40 mg, 80 mg, 160 mg, 320 mg
  • Actavis – Teva Pharmaceuticals USA Valsartan – 40 mg, 80 mg, 160 mg, 320 mg
  • A-S Medication Solutions LLC Valsartan – 80 mg, 160 mg
  • Bryant Ranch Prepack Inc Valsartan 80 mg, 320 mg
  • H J Harkins Company Valsartan – 160 mg
  • Northwind Pharmaceuticals Valsartan – 80 mg, 160 mg, 320 mg
  • Quality Care Products LLC (Lake Erie Medical) Valsartan – all doses
  • NuCare Pharmaceuticals Valsartan – all doses
  • Proficient Rx Valsartan – all doses
  • Actavis – Teva Pharmaceuticals USA Valsartan w/ hydrochlorothiazide (HCTZ) 80 mg/12.5 mg, 160 mg/12.5 mg, 160 mg/25 mg, 320 mg/12.5 mg, 320 mg/25 mg
  • AvKARE valsartan w/ hydrochlorothiazide (HCTZ) 80 mg/12.5 mg, 160 mg/12.5 mg, 160 mg/25 mg, 320 mg/12.5 mg, 320 mg/25 mg
  • A-S Medication Solutions LLC 80 mg, 160 mg & valsartan w/ hydrochlorothiazide (HCTZ) 160 mg/12.5 mg, 320 mg/25 mg

Drug Law Center

According to the FDA, “it is possible that not all valsartan-containing products repackaged by these companies are impacted by the recall. The FDA continues to evaluate valsartan -containing products and will update the list of products included in the recall and the list of products not included in the recall as more information becomes available.”

An FDA Update

On July 27, 2018, the Food and Drug Administration updated their recall information concerning consumer use of impure valsartan-containing medications. The agency states that:

“The amounts of NDMA found in the recalled batches of valsartan exceeded these acceptable levels. The agency wanted to put some context around the actual potential risk posed to patients who used versions of valsartan that may have contained high levels of NDMA. Based on records from the manufacturer of the recalled valsartan, some levels of the impurity may have been in the valsartan-containing products for as long as four years. FDA scientists estimate that if 8,000 people took the highest valsartan dose (320 mg) from the recalled batches daily for the full four years, there may be one additional case of cancer over the lifetimes of these 8,000 people. This assessment led to FDA’s decision to have these batches recalled.”

On August 2, 2018, the FDA released their next update of the list of products added to the recall and stated that:

“FDA is working with drug manufacturers to ensure future valsartan active pharmaceutical ingredients (APIs) are not at risk of NDMA formation. The agency reminds manufacturers to thoroughly evaluate their API manufacturing processes, and changes to those processes, to detect any unsafe impurities. If a manufacturer detects new or higher levels of impurity, they should take action to prevent changes to the product’s safety profile.”

U.S. Joints 22 Other Countries’ Recall

In July 2018, the FDA (Food and Drug Administration) finally joined 22 other countries in North America (Canada), Asia and Europe in recalling medications containing contaminated valsartan. The FDA Director of the Center for Drug Evaluation and Research Dr. Janet Woodcock stated that:

“We have carefully assessed the valsartan-containing medication sold in the United States, and we have found that the valsartan sold by these specific companies does not meet are safety standards. This is why we have asked these companies to take immediate action to protect patients.”

FDA commissioner Dr. Scott Gottlieb said the federal agency is investigating the dangers of the drug and remains:

“Committed to maintaining our gold standard for safety and efficacy. That includes our efforts to ensure the quality of drugs and the safe manner in which they are manufactured. We will identify lapses in the quality of drugs and problems with their manufacturing that had the potential to create risks to patients, we are committed to taking swift action to alert the public and help facilitate the removal of the products from the market.” The doctor also stated that “as we seek the removal of certain drug products today, are drug shortages team is also working hard to ensure patients’ therapeutic needs are met in the United States with an adequate supply of unaffected medications.”

Reported Adverse Events

Taking the angiotensin II receptor blocker valsartan (Diovan) to control heart failure, post heart attack conditions and hypertension can produce side effects that include:

  • Back pain,
  • Blurred vision,
  • Cold symptoms including sore throat, sneezing, stuffy or runny nose, and coughing,
  • Dizziness and lightheadedness,
  • Flu symptoms,
  • Headaches,
  • Joint pain,
  • Nausea and diarrhea,
  • Palpitations,
  • Stomach pain,
  • Swelling around the eyes or lips,
  • Swelling,
  • Tiredness and fatigue,
  • Unexpected weight loss,
  • Upper respiratory infections,
  • Vomiting.

More serious side effects involve:

  • Chest flutters, pounding heart beats, loss of appetite, increase thirst, confusion weakness,
  • High potassium response including a tingling sensation, muscle weakness, week pulse, or slowed heart rate.
  • Rapid weight loss
  • Shortness of breath occurring with just mild exertion,
  • Unusual increase urinating volume.

The FDA recommends that patients speak with their doctors about the medications they are taking before discontinuing any drug without their doctor’s permission. The American Heart Association says that quitting a medication without supervision could be dangerous to the patient’s health.

According to the American Academy of Family Physicians, doctors should “advise patients to contact the health care professional who prescribed the medication or the pharmacist who dispensed it if their prescription is included in the recall to discuss their treatment. This could include prescribing another valsartan product not affected by the recall or an alternative treatment option …”

Do You Have Questions About Your Legal Options Related To The Valsartan Recall?

Attorneys at the Drug Law Center are currently reviewing all types of cases related medical complication associated with Valsartan. If you or a family member experienced serious medical side effects or developed cancer after taking Valsartan, contact our office for a free review of your legal rights and options for a financial recover. All consultations are free and confidential.

Continue reading

Published on:

Epi Pen Go WrongNOTICE: The Drug Law Center is no longer accepting these type of cases. This page is strictly for informational purposes. We appreciate your cooperation and understanding by not contacting our office on these cases. We are actively investigating and prosecuting cases involving Valsartan cancers. For information on Valsartan lawsuits, look here.

In August 2017, the U.S. Attorney’s Office of the Federal Justice Department announced that Mylan Inc., a large pharmaceutical company, and Mylan Specialty L.P. settled a federal liability case by paying $465 million. The federal government had alleged that both companies violated the U.S. False Claims Act when they misclassified their brand-name EpiPen ‘epinephrine delivering device’ as a generic product, which allowed them to underpay Medicaid on earned rebates.

This financial settlement agreement followed the March 2017 announcement by Pennsylvania-based Mylan N.V. that their manufacturing partner Pfizer-owned Meridian Medical Technologies would expand a voluntary recall of their defective EpiPen auto injectors. This involved selected lots of the brand-name delivery device that included the EpiPen and EpiPen Junior. The generic forms of the epinephrine delivery device were not included in the voluntary recall.

Published on:

Scoliosis Magnetic SystemNOTICE: The Drug Law Center is no longer accepting these type of cases. This page is strictly for informational purposes. We appreciate your cooperation and understanding by not contacting our office on these cases. We are actively investigating and prosecuting cases involving Valsartan cancers. For information on Valsartan lawsuits, look here.

The Nuvasive Magec System is an effective magnetic technology that treats scoliosis using adjustable growing rods. In the past, these growing rods needed to be replaced during follow-up surgeries. However, the latest minimally invasive technology allows the rods to be adjusted using an external remote controller to avoid repeated surgical procedures. The newly redesigned Nuvasive Magec System can treat idiopathic and early-onset scoliosis.

In early September 2016, the Food and Drug Administration cleared the Nuvasive spinal implant system to treat patients suffering from early-onset scoliosis involving comprehensive spinal deformities. Their “RELINE” device is the only available small stature system manufactured with ‘easy to use’ components and small adjustable rods to maximize successful surgical outcomes in the U.S. The FDA 501(K) clearance indicates that the adjustable rods are safe to use with Magnetic Resonance Imaging (1.5 T) devices.

Published on:

Heating and Cooling Patient Sorin 3TNOTICE: The Drug Law Center is no longer accepting these type of cases. This page is strictly for informational purposes. We appreciate your cooperation and understanding by not contacting our office on these cases. We are actively investigating and prosecuting cases involving Valsartan cancers. For information on Valsartan lawsuits, look here.

The Sorin 3T Heater Cooler System is an advanced medical device used in operating rooms around the world. The machine regulates the patient’s body temperature during complex heart surgeries that require the heart and the flow of blood to be stopped during the procedure. Germany-based LivaNova Inc, the manufacturer of Sorin 3T Heater Cooler, created the device that uses three unique circuits to make sure the patient’s body is sufficiently heated or cooled throughout the surgery. However, in recent years, the machine has been linked to TM (non-tuberculosis mycobacteria) infections and other severe side effects.

Since the end of 2016, the manufacturer of the device, the Centers for Disease Control and Prevention (CDC), and hospitals throughout the U.S. have warned patients who have undergone cardiopulmonary operations involving the Sorin 3T Heater Cooler System. Their urgent warnings have informed patients of the potential risk of exposure to Mycobacterium chimaera contamination involving deadly bacteria that could potentially grow in the device’s water tank. If the bacteria are present, they can aerosolize from the machine and spread throughout the OR (operating room) and into the patient’s chest opened cavity through the air or through a transfer onto surgical tools.

Published on:

Heart Rate MedicationNOTICE: The Drug Law Center is no longer accepting these type of cases. This page is strictly for informational purposes. We appreciate your cooperation and understanding by not contacting our office on these cases. We are actively investigating and prosecuting cases involving Valsartan cancers. For information on Valsartan lawsuits, look here.

Amiodarone (pacerone & nexterone) is a medication formulated to improve heartbeat rhythm. Doctors prescribe the drug to patients with life-threatening ventricle-related heart rhythm disorders to ensure the heart beats normally. The ventricles are the heart’s lower chambers that allow blood flow out from the heart.

The medication Amiodarone (pacerone) is affected for treating ventricular fibrillation and ventricular tachycardia. The medication was first discovered in 1961 and received final FDA approval in December 1985. The drug has not been approved by the Food and Drug Administration (FDA) for any other condition.

Published on:

Mandibular FixatorNOTICE: The Drug Law Center is no longer accepting these type of cases. This page is strictly for informational purposes. We appreciate your cooperation and understanding by not contacting our office on these cases. We are actively investigating and prosecuting cases involving Valsartan cancers. For information on Valsartan lawsuits, look here.

The DePuy Synthes Craniomaxillofacial Distraction System (external mandibular fixator) consists of multiple internal distractors that stabilize or lengthen lower jaw bones and along the side of the lower jaw bone plate. Surgeons implant the device in adults, children, and infants to correct post-traumatic and congenital birth jaw bone defects. When installed properly, the distractors can gradually expand the length of the bone. DePuy Synthes is a subsidiary of the healthcare and pharmaceutical giant Johnson & Johnson.

FDA Alert Concerning Defective Design of DePuy Synthes Craniomaxillofacial Distraction System

Published on:

Tecfidera-infections from medicationNOTICE: The Drug Law Center is no longer accepting these type of cases. This page is strictly for informational purposes. We appreciate your cooperation and understanding by not contacting our office on these cases. We are actively investigating and prosecuting cases involving Valsartan cancers. For information on Valsartan lawsuits, look here.

Tecfidera (dimethyl fumarate) is a highly effective oral drug brought to the medical marketplace by Biogenic, Inc. to treat MS (multiple sclerosis). The Food and Drug Administration (FDA) approved the drug in March 2013 to prevent the relapse of MS. However, one reported case has been noted on the updated FDA drug label (December 2014) linking Tecfidera (dimethyl fumarate) taken for multiple sclerosis with progressive multifocal leukoencephalopathy (PML), life-threatening brain infection.

This is the fourth case reported to the FDA, which resulted in an increased warning of the dangerous life-threatening side effects when taking medications to treat MS. The initial three cases of PML are apparently associated with the oral medication fingolimod among patients who had suffered severe low lymphocyte count (lymphopenia). However, the fourth case happened with “a patient with only moderate lymphopenia” that has raised concerning questions about Tecfidera’s effectiveness versus its safety.

Published on:

Recall of Zimmer ShouldersNOTICE: The Drug Law Center is no longer accepting these type of cases. This page is strictly for informational purposes. We appreciate your cooperation and understanding by not contacting our office on these cases. We are actively investigating and prosecuting cases involving Valsartan cancers. For information on Valsartan lawsuits, look here.

In 2008, Biomet, Inc. launched their medical Comprehensive Reverse Shoulder System Humeral Tray device as a shoulder replacement implant to restore a patient’s arm movement. The clearance of the device by the Food and Drug Administration (FDA) bypassed the need for human clinical trials. Instead, the device was made available in the medical marketplace under the 510(K) fast-track program after Biomet showed that their new device was “substantially equivalent” to other shoulder replacement devices that had been previously approved by the FDA previously.

The comprehensive reverse shoulder system by Zimmer Biomet (in 2015, Zimmer Holdings acquired Biomet) provided significant benefits to patients who are suffering from rotator cuff tears who have developed severe shoulder arthritis arthroplasty conditions. In addition, surgeons use the new reverse shoulder system for patients who require a joint replacement from a previously failed implant device. When properly surgically implanted, the shoulder replacement device assists patients by restoring their arm movement.

Published on:

NOTICE: The Drug Law Center is no longer accepting these type of cases. This page is strictly for informational purposes. We appreciate your cooperation and understanding by not contacting our office on these cases. We are actively investigating and prosecuting cases involving Valsartan cancers. For information on Valsartan lawsuits, look here.

The vaccination injury attorneys at the Drug Law Center remain committed to representing our clients who have been harmed by vaccines to ensure they receive financial compensation.

What are Vaccines?

Published on:

NOTICE: The Drug Law Center is no longer accepting these type of cases. This page is strictly for informational purposes. We appreciate your cooperation and understanding by not contacting our office on these cases. We are actively investigating and prosecuting cases involving Valsartan cancers. For information on Valsartan lawsuits, look here.

The infection injury attorneys at the Drug Law Center are reviewing and accepting cases from clients who suffered injuries caused by preventable superbugs.

What are Superbugs?

Client Reviews

★★★★★
My family feels a sense of closure with the help of the attorneys at the Drug Law Center. They did a tremendous job.

About the Drug Law Center

The Drug Law Center is sponsored by lawyers who represent individuals and families who have suffered a serious injury or death from a dangerous drug or medical device. While these medical inventions have been marketed to improve the quality of life for people, unsafe drugs and poorly designed medical devices can drastically reduce the quality of life for the individual and his or her family.